-+ 0.00%
-+ 0.00%
-+ 0.00%

Radiopharm Theranostics Reports 92% Success Rate for RAD 101 in Phase 2b Brain Metastases Trial

路透·12/15/2025 12:00:48

登錄查看新聞詳情